We are live on ! Find out more
SER icon

Serina Therapeutics
SER

22 hedge funds and large institutions have $822K invested in Serina Therapeutics in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.48% less ownership

Funds ownership: 4.5% → 4.03% (-0.48%)

12% less funds holding

Funds holding: 25 → 22 (-3)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

67% less capital invested

Capital invested by funds: $2.48M → $822K (-$1.65M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
22
Holders Change
-3
Holders Change %
-12%
% of All Funds
0.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
–
Increased
4
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$16.7K
2
Wells Fargo
Wells Fargo
California
+$14.6K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$3.24K
4
TRCT
Tower Research Capital (TRC)
New York
+$1.16K

Top Sellers

Rank Fund Capital Flow
1
BC
Broadwood Capital
New York
-$116K
2
HighTower Advisors
HighTower Advisors
Illinois
-$25.2K
3
Citigroup
Citigroup
New York
-$12.5K
4
UBS Group
UBS Group
Switzerland
-$12.3K
5
Northern Trust
Northern Trust
Illinois
-$1.84K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$344K – – –
WA
2
Waverly Advisors
Alabama
$129K – – –
BC
3
Broadwood Capital
New York
$104K -$116K -28,711 -35%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$58.2K +$3.24K +801 +3%
LW
5
Linscomb Wealth
Texas
$36K – – –
KP
6
Keel Point
Alabama
$34K – – –
BlackRock
7
BlackRock
New York
$33K +$16.7K +4,127 +31%
Northern Trust
8
Northern Trust
Illinois
$26.9K -$1.84K -455 -3%
State Street
9
State Street
Massachusetts
$24.4K – – –
HighTower Advisors
10
HighTower Advisors
Illinois
$22.9K -$25.2K -6,231 -34%
Wells Fargo
11
Wells Fargo
California
$6.89K +$14.6K +3,602 +180,100%
TRCT
12
Tower Research Capital (TRC)
New York
$859 +$1.16K +286 +175%
UBS Group
13
UBS Group
Switzerland
$829 -$12.3K -3,033 -88%
PSB
14
Piscataqua Savings Bank
New Hampshire
$53 – – –
PP
15
Pacifica Partners
Canada
$17 – – –
AFG
16
Albion Financial Group
Utah
$16 – – –
Morgan Stanley
17
Morgan Stanley
New York
$15 – – –
Bank of America
18
Bank of America
North Carolina
$6 -$858 -212 -99%
BNP Paribas Financial Markets
19
BNP Paribas Financial Markets
France
$4 – – –
Rockefeller Capital Management
20
Rockefeller Capital Management
New York
$4 – – –
Osaic Holdings
21
Osaic Holdings
Arizona
$2 -$36 -9 -82%
GRP
22
Global Retirement Partners
California
$2 – – –
Citigroup
23
Citigroup
New York
– -$12.5K -2,323 Closed
ASN
24
Advisory Services Network
Georgia
– -$75 -14 Closed
JP Morgan Chase
25
JP Morgan Chase
New York
– -$54 -10 Closed

SER Hedge Fund Activity: Q4 2025 in Review

22 of the 8,245 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q4 2025, worth a combined $822K — down 67% from $2.48M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of SER and 0 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 4 added.

The largest buyer was BlackRock, adding an estimated $16.7K. The largest seller was Broadwood Capital, cutting an estimated $116K.

  • 22 institutional investors held Serina Therapeutics (SER) as of Q4 2025, down from 25 in Q3 2025.
  • Funds reported $822K of Serina Therapeutics stock for Q4 2025, down 67% quarter-over-quarter.
  • 0 funds opened new Serina Therapeutics positions in Q4 2025 and 3 closed out, a net change of -3 holders.
  • The largest Serina Therapeutics buyer in Q4 2025 was BlackRock, an estimated $16.7K added.
  • The largest Serina Therapeutics seller in Q4 2025 was Broadwood Capital, an estimated $116K sold.

Based on aggregated 13F filings for Q4 2025.